Margaret Clagett-Dame
Corporate Officer/Principal bij University of Wisconsin
Profiel
Margaret Clagett-Dame was the founder of Deltanoid Pharmaceuticals, Inc. which was founded in 1999, where she held the title of Director & Executive Vice President.
Currently, she is a Professor at the University of Wisconsin since 1989.
Dr. Clagett-Dame has a graduate degree from The Pennsylvania State University and a doctorate degree from the University of Wisconsin.
Actieve functies van Margaret Clagett-Dame
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Wisconsin | Corporate Officer/Principal | 01-01-1989 |
Eerdere bekende functies van Margaret Clagett-Dame
| Bedrijven | Functie | Einde |
|---|---|---|
Deltanoid Pharmaceuticals, Inc.
 Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI. | Oprichter | - |
Opleiding van Margaret Clagett-Dame
| University of Wisconsin | Doctorate Degree |
| The Pennsylvania State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Deltanoid Pharmaceuticals, Inc.
Deltanoid Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Deltanoid Pharmaceuticals, Inc. researches and develops therapies for the treatment of human diseases. The firm's focus is to move therapies in a variety of areas, including renal disease, osteoporosis, vitamin D deficiency, and acne through the drug development process and seek partners for later stage development and commercialization. The company was founded by Margaret Clagett-Dame and Hector F. DeLuca in 1999 and is headquartered in Madison, WI. | Commercial Services |